Seed and Venture Capital Schemes Report 2025 (Enterprise Ireland)
Largest segment
30% Healthcare and Life Sciences
Largest sectoral investment share (2019-2024 by value) p.11
Summary
- In 2025, Enterprise Ireland made its first allocations under the €250 million Seed & Venture Capital Scheme (SVC) 2025-2029, approving up to €120 million for venture capital funds.p.5
- Total investment into Irish technology companies reached €1.1 billion in 2025, representing a 23% decline compared to 2024.p.6
- The average investment per Irish company under the SVC 2025 activity was €542k, leveraging 4x additional capital.p.7
- Women-led businesses accounted for 20% of the companies receiving investment through Enterprise Ireland-supported funds in 2025.p.5
- Enterprise Ireland has committed over €700 million through successive SVC Schemes, leveraging over €1.5 billion of investment into the Irish venture capital ecosystem.p.5
Key insights
- Enterprise Ireland launched initial allocations under the new €250 million SVC Scheme 2025-2029, committing up to €120 million to early-stage venture capital funds.p.5
- Venture capital funding in Irish technology companies decreased by 23% in 2025 to €1.1 billion, marking the first annual decline since 2018.p.6
- Enterprise Ireland-backed funds deployed €84 million into 81 Irish companies across healthcare, life sciences, digital services, and fintech sectors in 2025.p.6
- Investments in 2025 averaged €542k per Irish company and successfully leveraged 4x in additional capital.p.7
- Female-led enterprises represented 20% of all companies funded by Enterprise Ireland-supported funds in 2025.p.5
- Under the 2019-2024 SVC Scheme, Healthcare and Life Sciences accounted for the largest sectoral share of Irish investments by value at 30%.p.11
Topics and entities
EuropePublic funding and grantsStartup ecosystemsStartup fundingVenture capitalACT Venture CapitalAtlantic BridgeDelta PartnersEarlybirdElkstone PartnersEnterprise IrelandFinch CapitalFountain Healthcare PartnersFurthr VCIrish Venture Capital AssociationMiddleGame VenturesSeroba Life SciencesSure Valley Ventures
Summary and figures generated from the document and checked automatically: every number shown appears on the cited page. The full document is available from the publisher. Publishers can request removal.